// App-Quantinova.ai

e17057 : The impact of COVID-19 on delivery of systemic anti-cancer treatment in urological cancer patients: A comparison with 2019 data from Guy’s Cancer Center.

Researchers

Presenter

  • Christina Karampera

Principal Investigators

  • Muhammad Khan

  • Beth Russell

  • Charlotte Moss

  • Maria J Monroy-Iglesias

  • Saoirse Dolly

  • Kiruthikah Thillai

  • Debra Hannah Josephs

  • Elias Pintus

  • Sarah Rudman

  • Mieke Van Hemelrijck

  • Deborah Enting

Medical Centers

  • Guy's and St Thomas' NHS Foundation Trust, Critical Care Medicine, London, United Kingdom

  • Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, United Kingdom

  • Department of Translational Oncology and Urology Research, King's College London, London, United Kingdom

  • Department of Translational Oncology and Urology Research, King's College London, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Urinary tract cancers

  • Coronavirus disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved